Xylem (NYSE:XYL) was downgraded by analysts at Cowen from an “outperform” rating to a “market perform” rating in a report released on Tuesday, The Fly reports.
Several other equities research analysts also recently weighed in on the stock. BMO Capital Markets reissued a “buy” rating and issued a $85.00 target price on shares of Xylem in a research report on Monday, February 25th. Zacks Investment Research downgraded shares of Xylem from a “hold” rating to a “sell” rating in a research report on Friday, April 5th. ValuEngine downgraded shares of Xylem from a “buy” rating to a “hold” rating in a research report on Monday, February 4th. Oppenheimer set a $80.00 price objective on shares of Xylem and gave the company a “buy” rating in a research report on Monday, February 4th. Finally, Janney Montgomery Scott raised shares of Xylem from a “neutral” rating to a “buy” rating and set a $86.00 price objective for the company in a research report on Friday, May 3rd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and ten have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $79.80.
XYL opened at $76.80 on Tuesday. The stock has a market capitalization of $14.23 billion, a PE ratio of 26.67, a P/E/G ratio of 1.48 and a beta of 1.15. Xylem has a 1-year low of $60.65 and a 1-year high of $84.41. The company has a quick ratio of 1.02, a current ratio of 1.44 and a debt-to-equity ratio of 0.73.
In other news, Director Curtis J. Crawford sold 7,500 shares of the company’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $79.20, for a total value of $594,000.00. Following the completion of the sale, the director now directly owns 19,244 shares of the company’s stock, valued at approximately $1,524,124.80. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Claudia S. Toussaint sold 2,344 shares of the company’s stock in a transaction that occurred on Wednesday, May 1st. The stock was sold at an average price of $83.71, for a total transaction of $196,216.24. Following the completion of the sale, the senior vice president now directly owns 46,105 shares of the company’s stock, valued at $3,859,449.55. The disclosure for this sale can be found here. Insiders have sold a total of 59,513 shares of company stock valued at $4,700,540 over the last three months. 0.85% of the stock is currently owned by company insiders.
Large investors have recently modified their holdings of the company. Sandy Spring Bank lifted its stake in shares of Xylem by 101.2% in the 1st quarter. Sandy Spring Bank now owns 338 shares of the industrial products company’s stock worth $27,000 after acquiring an additional 170 shares during the period. Cullen Frost Bankers Inc. acquired a new stake in shares of Xylem in the 1st quarter worth approximately $28,000. Liberty Wealth Management LLC acquired a new stake in shares of Xylem in the 4th quarter worth approximately $35,000. Doyle Wealth Management acquired a new stake in shares of Xylem in the 4th quarter worth approximately $36,000. Finally, Harvest Group Wealth Management LLC acquired a new stake in shares of Xylem in the 1st quarter worth approximately $46,000. 87.13% of the stock is owned by institutional investors.
Xylem Company Profile
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
Featured Story: What is the price-sales ratio?
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.